Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Plasmacytoma × Leukapheresis × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 2 Waldenstrom Macroglobulinemia 1 Plasmacytoma 1 Lymphoma, Non-Hodgkin 1 Leukemia 1 Hodgkin Disease 1

Interventions

silmitasertib 1 daratumumab 1 Leukapheresis 1 Drug Combinations 1 CF regimen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04665076 2020-12-11

Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell Tumors

Hebei Senlang Biotechnology Inc., Ltd.

Phase NA Unknown

Plasmacytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡